Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein reported record third-quarter net sales of $3.2 billion, marking an 11.9% increase year-over-year. GAAP diluted EPS rose to $1.15 from $0.99, while non-GAAP diluted EPS reached $1.10, up from $1.03. The company raised its 2021 non-GAAP diluted EPS guidance to between $4.27 and $4.35, reflecting a growth of 44% to 46% compared to 2020. Preliminary guidance for 2022 indicates mid to high single-digit growth over the 2021 guidance. Strong sales growth was seen across Global Dental and Medical segments.
Henry Schein (Nasdaq: HSIC), a leading provider of health care solutions, has committed to a long-term goal of net-zero emissions by 2050. The company has signed the Business Ambition for 1.5⁰C initiative, aiming to set science-based emissions reduction targets. This move is part of a broader strategy to address climate change and improve sustainability within the health care supply chain. Henry Schein will focus on establishing emissions metrics across key markets in North America, Europe, and Australia.
Henry Schein (Nasdaq: HSIC) announced its support for two Mission of Mercy events in Pittsburgh, PA (10/22-10/23) and Phoenix, AZ (12/9-12/11) as part of a three-year commitment to America's Dentists Care Foundation (ADCF). The company will donate up to
Henry Schein, the leading provider of health care solutions for dental and medical practitioners, will present virtually at the Credit Suisse 30th Annual Healthcare Conference on November 9, 2021, at 10:30 am Eastern time. The presentation will be available via live webcast at www.henryschein.com/IRwebcasts, with a replay accessible afterward. As a FORTUNE 500 Company, Henry Schein operates in 32 countries, serving over 1 million customers with more than 300 solutions for improved operational success.
Henry Schein, the leading provider of health care solutions, will release its third quarter 2021 financial results before the market opens on November 2, 2021. A live webcast of its earnings conference call will begin at 10:00 a.m. Eastern time the same day. Key speakers include Stanley M. Bergman, Chairman and CEO, and Steven Paladino, CFO. Investors can access the call at www.henryschein.com/IRwebcasts. Henry Schein operates globally with over 21,000 team members and reported sales of $10.1 billion in 2020.
Henry Schein supports a coalition of physician organizations urging the Biden Administration to expedite access to COVID-19 vaccines for primary-care physicians. CEO Stanley M. Bergman highlighted ongoing vaccination challenges in communities of color and rural areas, emphasizing the role of trusted office-based physicians in addressing vaccine hesitancy. The push aims to close vaccination gaps as the CDC updates guidance allows for simultaneous administration of flu and COVID-19 vaccines. The company continues to focus on health equity amidst efforts to improve vaccine distribution.
Henry Schein, Inc. (NASDAQ: HSIC) launched its 24th annual ‘Back to School’ program, providing backpacks filled with supplies to nearly 4,500 children across 22 locations in the U.S., Canada, Spain, and Ireland. Since 1998, the initiative has supported over 60,000 children. The program underscores the company's commitment to corporate social responsibility through Henry Schein Cares. Executive VP Gerry Benjamin highlighted the program's adaptability during the pandemic, emphasizing the importance of helping children return to school with confidence.
Henry Schein, Inc. has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer. Graham will enhance communications with investors and oversee key financial initiatives. With extensive experience in finance management, he previously served as CFO of Henry Schein's Global Dental Group. The company, a leader in health care solutions, operates globally, serving over 1 million customers. In 2020, Henry Schein generated $10.1 billion in sales, growing at a compound annual rate of approximately 12% since becoming public in 1995.